Pre-B-Cell Leukemia Homeobox Protein 1 (PBX1) Peptide
PBX1
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN981410
Aperçu rapide pour Pre-B-Cell Leukemia Homeobox Protein 1 (PBX1) Peptide (ABIN981410)
Antigène
PBX1
(Pre-B-Cell Leukemia Homeobox Protein 1 (PBX1))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-PBX1 antibody (Catalog #: ARP30948_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PBX1 (Pre-B-Cell Leukemia Homeobox Protein 1 (PBX1))
-
Sujet
-
PBX1 binds the sequence 5'-ATCAATCAA-3'. It acts as a transcriptional activator of PF4 in complex with MEIS1. It may be converted into a potent transcriptional activator by the (1,19) translocation. It also may have a role in steroidogenesis and, subsequently, sexual development and differentiation.
Alias Symbols: DKFZp686B09108, MGC126627
Protein Interaction Partner: PAX6,HOXA10,HOXA5,HOXA9,HOXB1,HOXB8,HOXD10,HOXD4,MEIS1,MYH10,NR3C1,PAX6,PBX2,PKNOX1,SMARCD3,HOXA9,HOXB1,HOXB7,HOXB8,HOXD4,HOXD9,MEIS1,MYH10,MYOD1,Myh10,NR3C1,PKNOX1
Protein Size: 430 -
Poids moléculaire
- 47 kDa
-
ID gène
- 5087
-
NCBI Accession
- NM_002585, NP_002576
-
UniProt
- P40424
Antigène
-
Vous êtes ici:
